• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD face a difficult decision about whether to continue or stop taking ADHD medication during pregnancy and breast-feeding. There isn't much information on how long-term exposure to these drugs may affect the fetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems like hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge that more high-quality studies are needed.

Risk/Benefit Analysis

Pregnant women who use ADHD medications must weigh the benefits of taking them against the potential risks to the foetus. Doctors don't have the data needed to provide clear recommendations, but they can provide information on benefits and risks that can assist pregnant women in making informed decisions.

A study published in Molecular Psychiatry found that women who used ADHD medications in early pregnancy did not have an increased risk of fetal cardiac malformations or major structural birth defects. Researchers used a vast, population-based case-control study to determine the prevalence of major structural birth defects in infants born to mothers who had taken stimulants during early pregnancy, as well as those who had not. Pediatric cardiologists, clinical geneticists and other experts looked over the cases to ensure that the classification was correct and to minimize any bias.

The study conducted by the researchers was not without its limitations. Most important, they were unable to separate the effects of the medication from the disorder at hand. This limitation makes it difficult for researchers to establish whether the few associations observed between the groups that were exposed to the use of medications, or if they were caused by comorbidities. In addition the study did not look at the long-term effects of offspring on their parents.

The study revealed that infants whose mothers took inattentive adhd medication adults medication during pregnancy had a higher chance of being admitted to the neonatal care unit (NICU), compared to mothers who didn't take any medication during pregnancy, or had stopped taking their medication before or during pregnancy. This increase was due to central nervous system-related disorders and the increased risk for admission was not found to be influenced by which stimulant medications were taken during pregnancy.

Women who took stimulant ADHD medications used to treat adhd during pregnancy also had a higher risk of having to have a caesarean section or one whose baby scored low on the Apgar scale (less than 7). These increases did appear to be independent of the type of medication taken during pregnancy.

Researchers suggest that the minor risks associated with the use ADHD medications during early pregnancies may be offset by the greater benefits to both mother and baby from continuing treatment for the woman's disorder. Physicians should discuss the issue with their patients and, where they are able, assist them in developing strategies to improve coping skills that may minimize the negative impact of her condition on her daily life and relationships.

Medication Interactions

More and more doctors are confronted with the dilemma of whether to continue treatment or stop during pregnancy as more women are diagnosed with ADHD. These decisions are frequently made without clear and authoritative evidence. Instead, doctors must consider their own expertise and experience, as well as the experiences of other doctors, and the research on the subject.

The issue of potential risks to the infant can be extremely difficult. The research that has been conducted on this topic is based on observation rather than controlled studies and many of the findings are contradictory. Most studies restrict their analysis to live-births, which could underestimate the severity of teratogenic effects which can cause abortions or terminations of pregnancy. The study presented in the journal club addresses these issues by analyzing both the data from deceased and live births.

The conclusion is that while certain studies have demonstrated a positive association between ADHD medications and the risk of certain birth defects, other studies have found no connection, and most studies show a neutral or even slight negative effect. As a result, a careful risk/benefit assessment must be done in each instance.

For a lot of women with ADHD and ADD, the decision to discontinue medication is difficult, if not impossible. In a recent piece published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of loneliness. The loss of medication can general practitioners prescribe adhd medication (Writeablog.net) also affect the ability to safely drive and to perform work-related tasks which are crucial aspects of daily life for people with ADHD.

She suggests that women who are not sure whether to continue taking the medication or stop it due to their pregnancy, educate their family members, colleagues, and friends about the condition, its impact on daily functioning and the advantages of staying on the current treatment. It can also help women feel supported in her decision. Some medications can pass through the placenta. If a woman decides to stop taking her ADHD medication while pregnant and breastfeeding, it is crucial to be aware that the drug may be transferred to her infant.

Birth Defects and Risk of

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) grows there are concerns about what impact the drugs could have on fetuses. A recent study published in the journal Molecular Psychiatry adds to the existing knowledge on this subject. Utilizing two huge data sets researchers were able to examine more than 4.3 million pregnancies and see whether stimulant medication use increased the risk of birth defects. Researchers discovered that, while the overall risk is low, the first trimester ADHD exposure to medication was associated with slightly higher rates of specific heart defects like ventriculoseptal defect.

The authors of the study could not discover any link between the use of early medications and other congenital anomalies like facial deformities, or club feet. The results are consistent with previous studies revealing an increase, but not significant, in the risk of developing cardiac malformations among women who started taking ADHD medications prior to pregnancy. The risk grew in the latter half of pregnancy, when many women begin to discontinue their ADHD medications.

Women who were taking ADHD medication during the first trimester were more likely need a caesarean or have an insufficient Apgar after delivery, and had a baby that required breathing assistance at birth. The authors of the study were not able to eliminate bias due to selection because they restricted the study to women with no other medical conditions that might have contributed to the findings.

Researchers hope that their study will help doctors when they encounter pregnant women. They suggest that although the discussion of risks and benefits is important however, the decision to stop or keep medication should be based on the woman's requirements and the severity of her ADHD symptoms.

The authors also warn that, while stopping the medication is an option, it isn't an option that is recommended due to the high rate of depression and other mental health problems in women who are pregnant or postpartum. Additionally, the research suggests that women who choose to stop taking their medications are more likely to experience a difficult time getting used to life without them following the birth of their baby.

Nursing

It can be overwhelming to become a mom. Women with ADHD who have to deal with their symptoms while attending physician appointments as well as getting ready for the arrival of their child and adjusting to new household routines can experience severe challenges. This is why many women decide to continue taking their ADHD medications throughout pregnancy.

The risk to a nursing infant is low because the majority of stimulant medications passes through breast milk at low levels. The rate of medication exposure can vary depending upon the dosage and frequency of administration as well as the time of day. In addition, different drugs enter the infant's system through the gastrointestinal tract or through breast milk. The effect on the health of a newborn isn't fully comprehended.

Some doctors may decide to stop stimulant medications during a woman's pregnancy due to the lack of research. This is a difficult choice best medicine for adhd and social anxiety the patient, who must balance the benefits of keeping her medication with the potential dangers to the foetus. Until more information becomes available, GPs may ask pregnant patients whether they have a history of ADHD or if they are planning to take medication in the perinatal stage.

Numerous studies have demonstrated that women can continue to take their ADHD medication in a safe manner during pregnancy and while breast-feeding. In response, a growing number of patients are opting to do so. They have found, in consultation with their doctors that the benefits of keeping their current medication outweigh any potential risks.

It is essential for women with ADHD who are considering breastfeeding to seek a specialist psychiatrist's advice prior to becoming pregnant. They should discuss their medication with their prescriber and discuss the pros and cons of continued treatment, including non-pharmacological strategies. Psychoeducation should also be provided to help pregnant people with ADHD be aware of their symptoms and the underlying disorder, learn about available treatment options and strengthen existing strategies for managing. This should be a multidisciplinary approach with the GPs, obstetricians and psychiatry. Pregnancy counseling should consist of a discussion of a treatment plan for the mother and the child, monitoring of signs of deterioration and, if needed adjustments to the medication regimen.